L-NAME, a nitric oxide synthase inhibitor, modulates cholinergic antinociception

Methods and Findings in Experimental and Clinical Pharmacology

Volumn 21, Issue 3, 1999, Pages 161-165

  Jain, Naveen K ^a   Kulkarni, Shrinivas K ^a  

^a PANJAB UNIVERSITY   (India)

Author keywords

5 HT(1A) receptor; Buspirone; Cholinergic antinociception; L NAME; Nitric oxide; Sumatriptan

Indexed keywords

ACETIC ACID; ANTIMIGRAINE AGENT; ATROPINE; BUSPIRONE; N(G) NITROARGININE METHYL ESTER; NALOXONE; NITRIC OXIDE SYNTHASE INHIBITOR; OPIATE ANTAGONIST; PHYSOSTIGMINE; PINDOLOL; SEROTONIN 1A AGONIST; SEROTONIN 1A ANTAGONIST; SEROTONIN 1A RECEPTOR; SUMATRIPTAN;

ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENTIATION; ENZYME INHIBITION; FEMALE; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MIGRAINE; MOUSE; NONHUMAN; SEROTONINERGIC SYSTEM; SUBCUTANEOUS DRUG ADMINISTRATION; WRITHING TEST;

ACETIC ACID; ANALGESICS; ANIMALS; BUSPIRONE; CHOLINERGIC AGENTS; DRUG SYNERGISM; ENZYME INHIBITORS; FEMALE; MALE; MICE; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PAIN; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS; SEROTONIN ANTAGONISTS; SUMATRIPTAN;

EID: 0033053007     PISSN: 03790355     EISSN: None     Source Type: Journal    
DOI: 10.1358/mf.1999.21.3.534824     Document Type: Article

References (31)

1. Moncada, S., Palmer, R.M.J., Higgs, E.A. Nitric Oxide: Physiology, pathophysiology and pharmacology. Pharmacol Rev 1991, 43: 109-42.
2. Moncada, S. The 1991 Ulf von Euler lecture. The L-arginine nitric oxide pathway. Acta Physiol Scand 1992, 145: 201-27.
3. Meller, S.T., Gebhart, G.F. Nitric oxide (NO) and nociceptive processing in the spinal cord. Pain 1993, 52: 127-36.
4. Garthwaite, J., Charles, S.L., Chess-Williams, R. Endothelium-derived relaxing factor release on activation of NMDA receptors suggest role as intercellular messenger in the brain. Nature 1988, 336: 385-8.
5. Garthwaite, J., Southam, E., Anderton, M. A kainate receptor linked to nitric oxide synthesis from L-arginine. J Neurochem 1989, 33: 1952-4.
6. Knowles, R. G., Palacious, M., Palmer, R.M.J., Moncada, S. Formation of nitric oxide from L-arginine in the central nervous system: Transduction mechanism for stimulation of soluble guanylate cyclase. Proc Natl Acad Sci USA 1989, 86: 5158-62.
7. Lassen, L.H., Ashina, M., Christiansen, I., Ulrich, V., Olesen, J. Nitric oxide synthase inhibitor in migraine. Lancet 1997, 349: 401-2.
8. Olesen, J., Thomsen, L.L., Iversen, H. Nitric Oxide is a key molecule in migraine and other vascular headaches. Trends Pharmacol Sci 1994, 15: 149-53.
9. Thomsen, L.L., Kruuse, C., Iversen, H.K., Olesen, J. A nitric oxide donor (nitroglycerin) triggers genuine migraine attacks. Eur J Neurol 1994, 1: 73-80.
10. t-receptor: Support for the NO hypothesis of migraine. Neuroreport 1995, 6: 1475-79.
11. G-amino L-arginine: A new potent antagonist of L-arginine-mediated endothelium-dependent relaxation. Biochem Biophys Res Commun 1990, 168: 458-65.
12. G-nitro arginine (L-NOARG), a novel arginine-reversible inhibitor of endothelium-dependent vasodilation in vitro. Br J Pharmacol 1990, 99: 408-12.
13. Ghelardini, C., Galeotti, N., Nicolodi, M., Donaldson, S., Sicuteri, F., Bartolini, A. Int J Clin Pharmacol Res 1997, 17(2-3): 105-9.
14. Hood, D.D, Eisenach, J.C., Tuttle, R. Phase I safety assessment of intrathecal neostigmine methyl sulphate in humans. Anesthesiology 1995, 82: 331-43.
15. Koster, R, Anderson, M., Debeer, E.J. Acetic acid for analgesic screening. Fed Proc 1959, 18: 412.
16. Kulkarni, S.K. Heat and other physiological stress induced analgesia catecholamine mediated and naloxone reversible response. Life Sci 1980, 27: 185-8.
17. G-nitro arginine (L-NOAKG), a selective inhibitor of nitric oxide biosynthesis exhibits antinociceptive activity in the mouse. Eur J Pharmacol 1990, 183: 1440-4.
18. Bartolini, A., Ghelardini, C., Fantetti, L., Macangio, M., Malmberg, A.P., Giotti, A. Role of muscarinic receptor subtypes in central antinociception. Br J Pharmacol 1992, 105: 77-82.
19. 1A receptor subtypes in the brain of control or 5,7-dihydroxy tryptamine treated rats. J Neurosci 1986, 6: 3474-84.
20. Dechant, K.L., Clissold, S.P. Sumatriptan : A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs 1992, 43(5): 776-98.
21. Taylor, D.P. Buspirone a new approach to the treatment of anxiety. FASEB J 1988, 2: 2445.
22. Ghelardini, C., Galeotti. N., Figni, M., Imperato, A., Nicolodi, M., Sicuteri, F., Gessa, G.L., Bartolini, A. The central cholinergic system has a role in the antinociception induced in rodents and guinea pigs by the anti-migraine drug sumatriptan. J Pharmacol Exp Ther 1996, 279: 884-90.
23. 3 agonists decrease acetylchotine efflux from the cerebral cortex of freely moving guinea-pigs. Br J Pharmacol 1990, 101: 448-52.
24. 1 agonist reduce 5-hydroxy tryptamine release in rat hippocampus in vivo is determined by brain micro dialysis. Br J Pharmacol 1989, 96: 283-90.
25. 1A receptor enhances acetylcholine release in conscious rats. J Neurochem 1994, 62: 1804-8.
26. Galeotti, N., Ghelardini, C., Bartolini, A. 5-HT1A agonists induce central cholinergic antinociception. Pharmacol Biochem Behav 1997, 57(4): 835-41.
27. Pavone, F., Capone, F., Populin, R., Prezewlocka, B. Nitric oxide synthase inhibitors enhance the antinociceptive effect of oxotremorine in mice. Pol J Pharmacol 1997, 49(1): 31-6.
28. Reddy, D.S., Kulkarni, S.K. The neuronal nitric oxide pathway plays an important role in the behavioral effects of corticotropin by mechanism other than those involving cardiovascular effects. Mol Cell Biochem 1998, 183: 25-38.
29. G-nitro arginine methyl ester inhibit antinociceplive activity in the mouse. Br J Pharmacol 1991, 102: 198-202.
30. Prous, J.R., Wroblewski, T., Castañer, J. Nitric oxide synthase inhibitor, treatment for septic shock, antimigraine. Drugs Fut 1998, 23(2): 123-32.
31. Machelska, H., Labuz, D., Prezewlocki, R., Prezewlocka, B. Inhibitor of nitric oxide synthase enhances antinociception mediated by mu, delta and Kopioid receptors in acute and prolonged pain in the rat spinal cord. J Pharmacol Exp Ther 1997, 282: 977-84.